In February 2019, a class-action lawsuit
was filed against L’Oréal for allegedly misleadingly marketing that Revitalift® products will affect the structure and function of skin by making unqualified claims that the products will lift, firm, and repair skin, as well as eliminate wrinkles, without meeting the FDA requirements to make such claims. (Borchenko et al v. L’Oréal
, Case No. 19-cv-1427, C. D. CA.)
For more of TINA.org’s coverage of cosmetics, click here.